Semma Therapeutics attracts funding
Cambridge, Massachusetts-based Semma Therapeutics, a developer of cell therapy for Type 1 diabetes, has raised an undisclosed amount of funding. The investor was JDRF T1D Fund, a venture philanthropy fund.
22 March 2017•3 mins read
